Persons with dispensed medicines; background; 2006-2020
| Sex | Age | Background and generation | Medicine group (ATC) | Periods | Persons with dispensed medicines (number) | Persons with medicines, relative (%) |
|---|---|---|---|---|---|---|
| Total male and female | Total age | Total background and generation | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Total background and generation | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Total background and generation | A07C Electrolytes with carbohydrates | 2020 | 5 | 0.00 |
| Total male and female | Total age | Total background and generation | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 1,590 | 0.01 |
| Total male and female | Total age | Total background and generation | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Total background and generation | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Dutch background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Dutch background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Dutch background | A07C Electrolytes with carbohydrates | 2020 | 5 | 0.00 |
| Total male and female | Total age | Dutch background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 1,190 | 0.01 |
| Total male and female | Total age | Dutch background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Dutch background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | With migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | With migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | With migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | Total age | With migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 400 | 0.01 |
| Total male and female | Total age | With migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | With migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 1st generation migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 1st generation migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 1st generation migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | Total age | 1st generation migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 250 | 0.01 |
| Total male and female | Total age | 1st generation migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 1st generation migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 2nd generation migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 2nd generation migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 2nd generation migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | Total age | 2nd generation migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 150 | 0.01 |
| Total male and female | Total age | 2nd generation migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | 2nd generation migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Western migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Western migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Western migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | Total age | Western migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 185 | 0.01 |
| Total male and female | Total age | Western migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Western migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Non-western migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Non-western migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Non-western migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | Total age | Non-western migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 215 | 0.01 |
| Total male and female | Total age | Non-western migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Non-western migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Other non-western background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Other non-western background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Other non-western background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | Total age | Other non-western background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 65 | 0.01 |
| Total male and female | Total age | Other non-western background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | Total age | Other non-western background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Total background and generation | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Total background and generation | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Total background and generation | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Total background and generation | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Total background and generation | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Total background and generation | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Dutch background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Dutch background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Dutch background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Dutch background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Dutch background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Dutch background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | With migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | With migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | With migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | With migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | With migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | With migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 1st generation migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 1st generation migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 1st generation migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 1st generation migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 1st generation migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 1st generation migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 2nd generation migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 2nd generation migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 2nd generation migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 2nd generation migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 2nd generation migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | 2nd generation migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Western migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Western migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Western migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Western migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Western migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Western migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Non-western migration background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Non-western migration background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Non-western migration background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Non-western migration background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Non-western migration background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Non-western migration background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | D07B Corticosteroids with antiseptics | 2020 | 0 | 0.00 |
| Total male and female | 0 to 14 years | Other non-western background | D07C Corticosteroids with antibiotics | 2020 | 0 | 0.00 |
| Total male and female | 15 to 24 years | Total background and generation | A03C Antispasmodics with psycholeptics | 2020 | 0 | 0.00 |
| Total male and female | 15 to 24 years | Total background and generation | A03D Antispasmodics with analgesics | 2020 | 0 | 0.00 |
| Total male and female | 15 to 24 years | Total background and generation | A07C Electrolytes with carbohydrates | 2020 | 0 | 0.00 |
| Total male and female | 15 to 24 years | Total background and generation | A11D Vitamin B1,and with vit. B6 and B12 | 2020 | 35 | 0.00 |
| Source: CBS. | ||||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.
Data are broken down by medicine group, background, generation, age and sex.
Data available from 2006 to 2020.
Status of the figures:
All figures are definite.
Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.
When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.
Description topics
- Persons with dispensed medicines
- Number of persons registered in the Basic Registration of Persons (BRP) in the year concerned to whom medicines are dispensed in that year that are reimbursed under the statutory basic medical insurance.
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.